33 results on '"Lazzarino, M."'
Search Results
2. Atomic force microscopy investigation of morphological changes in living keratinocytes treated with HgCl2 at not cytotoxic doses
3. A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications
4. Subcutaneous ‘lipoma-like’ B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT
5. Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation
6. Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients
7. Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia
8. Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis
9. Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients
10. Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma
11. Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes
12. Primary dermal melanoma occurring in a patient affected by Philadelphia-positive chronic myeloid leukaemia
13. Bartonella-related pseudomembranous angiomatous papillomatosis of the oral cavity associated with allogeneic bone marrow transplantation and oral graft-versus-host disease
14. A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma
15. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
16. Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy
17. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome
18. Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma
19. Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution
20. PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia
21. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome
22. Outcome and mortality in matched and mismatched unrelated haemopoietic stem cell transplantation after addition of thymoglobulin (ATG) to the conditioning regimen
23. Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies
24. Normal-looking skin in oncohaematological patients after allogenic bone marrow transplantation is not normal
25. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders
26. Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls
27. Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone
28. A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma
29. Lymph node reticulum cell neoplasm with progression into cytokeratin-positive interstitial reticulum cell (CIRC) sarcoma: a case study
30. Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients
31. Urinary proteins in multiple myeloma: correlation with clinical parameters and diagnostic implications
32. A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma
33. Time-Dependent Kinetics of Tretinoin in Chronic Myelogenous Leukaemia during Intermittent Dose Scheduling: 1 Week On/1 Week Off
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.